Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
暂无分享，去创建一个
J. Rosenstock | S. Garg | T. Bailey | B. Bode | S. Klein | Mark P. Christiansen | L. Klaff | J. Pettus | D. Thai | Douglas S. Denham | H. Akturk | Hai Yan | S. Boeder | Mickie H M Cheng | Edgar D Bautista | Ren Xu | D. Denham | Mickie H. M. Cheng | Edgar D. Bautista | M. Christiansen